Naloxone hydrochloride reverses the potentially fatal respiratory depression caused by opioid overdose and has been used increasingly since 1996. In October 2010, the Harm Reduction Coalition emailed a survey to the 50 programs known to distribute naloxone. From 1996-June 2010, programs reported providing training and distributing naloxone to an estimated 53,032 people and received reports of 10,171 overdose reversals using naloxone. Twenty-one (43.7 percent) programs reported problems obtaining naloxone in the “past few months” before the survey.
Related Articles on Pain Management:
USA Pain Professionals Opens in New Mexico
Three-Quarters of Healthcare Facilities Report Success Treating Chronic Pain With Integrative Medicine
Senate Committee Hears Testimony on Pain in America
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
